selected publications
- Survival in immune checkpoint inhibitor-treated patients with rheumatoid arthritis and non-small cell lung cancer: an observational cohort study. Arthritis care & research. 2025 Academic Article GET IT
- Comparison of targeted RNA sequencing platforms for oncogenic fusion detection in non-small cell lung cancer. The Journal of molecular diagnostics : JMD. 2025 Academic Article GET IT
- Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Nonsmall Cell Lung Cancer. Clinical lung cancer. 2024 Academic Article GET IT
- Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study. Rheumatology (Oxford, England). 2024 Academic Article GET IT
- Transferrin receptor-based circulating tumor cell enrichment provides a snapshot of the molecular landscape of solid tumors and correlates with clinical outcomes. 2024 GET IT
-
Ischemic Stroke with Comorbid Cancer Has Specific miRNA-mRNA Networks in Blood That Vary by Ischemic Stroke Mechanism.
Annals of neurology.
2024
Academic Article
GET IT
Times cited: 1 - Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment. Nature medicine. 2024 Academic Article GET IT
- Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis. 2024 GET IT
- Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. 2024 GET IT
- Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications. 2023 Academic Article GET IT
-
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2023
Guideline
GET IT
Times cited: 15 - Giving information strategically and transparently: A pilot trial of the Oncolo-GIST intervention to promote patients' prognostic understanding. Cancer medicine. 2023 Academic Article GET IT
-
Advancements in small cell lung cancer.
Seminars in cancer biology.
2023
Review
GET IT
Times cited: 35 -
Combining radiation therapy with immune checkpoint blockade for the treatment of small cell lung cancer.
Seminars in cancer biology.
2023
Review
GET IT
Times cited: 5 -
Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomes.
Journal of thrombosis and haemostasis : JTH.
2022
Academic Article
GET IT
Times cited: 20 -
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study.
Annals of neurology.
2021
Academic Article
GET IT
Times cited: 52 - Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment. American journal of clinical oncology. 2021 Academic Article GET IT
-
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.
The Lancet. Oncology.
2021
Academic Article
GET IT
Times cited: 125 -
Extracellular vesicles from human airway basal cells respond to cigarette smoke extract and affect vascular endothelial cells.
Scientific reports.
2021
Academic Article
GET IT
Times cited: 14 -
Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2021
Academic Article
GET IT
Times cited: 50 - Development of the Oncolo-GIST ("Giving Information Strategically & Transparently") Intervention Manual for Oncologist Skills Training in Advanced Cancer Prognostic Information Communication. Journal of pain and symptom management. 2020 Academic Article GET IT
-
Identification of a Microsatellite Stable, EGFR-Mutant Lung Adenocarcinoma Developing in a Patient With Lynch Syndrome.
JCO precision oncology.
2020
Academic Article
GET IT
Times cited: 2 -
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.
Annals of oncology : official journal of the European Society for Medical Oncology.
2020
Guideline
GET IT
Times cited: 107 -
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Academic Article
GET IT
Times cited: 167 -
Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile.
Stroke.
2019
Academic Article
GET IT
Times cited: 16 -
The lung microenvironment: an important regulator of tumour growth and metastasis.
Nature reviews. Cancer.
2019
Review
GET IT
Times cited: 821 -
Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations.
Blood.
2018
Academic Article
GET IT
Times cited: 27 -
Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2018
Academic Article
GET IT
Times cited: 68 - Molecular Testing for Stage IV Non-Small Cell Lung Cancer Patients With Targetable Mutations Following Disease Progression. Archives of pathology & laboratory medicine. 2018 Comment GET IT
-
Atezolizumab-Induced New Onset Diabetes Mellitus With Ketoacidosis.
American journal of therapeutics.
2018
Letter
GET IT
Times cited: 10 -
BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.
Oncotarget.
2016
Academic Article
GET IT
Times cited: 6 -
Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent.
Medical oncology (Northwood, London, England).
2016
Academic Article
GET IT
Times cited: 10 -
Therapeutic Effects of Repurposed Therapies in Non-Small Cell Lung Cancer: What Is Old Is New Again.
The oncologist.
2015
Review
GET IT
Times cited: 32 -
Double trouble: a case of concurrent de novo T790M and L858R EGFR mutations in treatment-naive advanced non-small-cell lung cancer.
2014
GET IT
Times cited: 3 -
Efficacy and safety of antiretrovirals in HIV-infected patients with cancer.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
2014
Academic Article
GET IT
Times cited: 51 -
Systemic therapy for small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN.
2013
Review
GET IT
Times cited: 16 -
Bortezomib-induced thrombotic thrombocytopaenic purpura.
2012
GET IT
Times cited: 25 -
Surgery for early-stage small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN.
2011
Review
GET IT
Times cited: 36 -
Intratracheally administered 5-azacytidine is effective against orthotopic human lung cancer xenograft models and devoid of important systemic toxicity.
Clinical lung cancer.
2010
Academic Article
GET IT
Times cited: 13 -
Structure-function analysis of the human TFIIB-related factor II protein reveals an essential role for the C-terminal domain in RNA polymerase III transcription.
Molecular and cellular biology.
2005
Academic Article
GET IT
Times cited: 23